These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 26144339)

  • 41. Changing stone composition profile of children with nephrolithiasis.
    Wood KD; Stanasel IS; Koslov DS; Mufarrij PW; McLorie GA; Assimos DG
    Urology; 2013 Jul; 82(1):210-3. PubMed ID: 23561713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
    Wilson DR; Pylypchuk G; Ehrig U
    Can Med Assoc J; 1979 Mar; 120(6):666-9. PubMed ID: 436048
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is there a risk for kidney stone formation in cystic fibrosis?
    Böhles H; Michalk D
    Helv Paediatr Acta; 1982 Jun; 37(3):267-72. PubMed ID: 7118558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children.
    Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D
    J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stone forming risk factors in patients with type Ia glycogen storage disease.
    Scales CD; Chandrashekar AS; Robinson MR; Cantor DA; Sullivan J; Haleblian GE; Leitao VA; Sur RL; Borawski KM; Koeberl D; Kishnani PS; Preminger GM
    J Urol; 2010 Mar; 183(3):1022-5. PubMed ID: 20092831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of ambient temperature, humidity and season of year on urine composition in patients with nephrolithiasis.
    Eisner BH; Sheth S; Herrick B; Pais VM; Sawyer M; Miller N; Hurd KJ; Humphreys MR
    BJU Int; 2012 Dec; 110(11 Pt C):E1014-7. PubMed ID: 22578009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Citrate and renal stones].
    del Valle EE; Spivacow FR; Negri AL
    Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The significance of hypocitruria in calcium oxalate induced nephrolithiasis].
    Horváth C; Németh J; Büki B; Vargha P
    Orv Hetil; 1990 Nov; 131(45):2475-8. PubMed ID: 2234941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Urinary phytate (Myo-inositol hexaphosphate) in healthy school children and risk of nephrolithiasis.
    Grases F; Saez-Torres C; Rodriguez A; Costa-Bauza A; Rodrigo D; Frontera G; Berga F; Fakier S
    J Ren Nutr; 2014 Jul; 24(4):219-23. PubMed ID: 24788309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative study of the circadian rhythmicity in the urinary concentration of glycosaminoglycans in patients of calcium oxalate nephrolithiasis and in healthy adults.
    Sidhu H; Thind SK; Nath R; Vaidyanathan S; Hemal AK; Mandal AK; Krishan K
    Urol Int; 1989; 44(4):218-21. PubMed ID: 2800054
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analyte variations in consecutive 24-hour urine collections in children.
    Ellison JS; Hollingsworth JM; Langman CB; Asplin JR; Schwaderer AL; Yan P; Bierlein M; Barraza MA; Defoor WR; Figueroa TE; Jackson EC; Jayanthi VR; Johnson EK; Joseph DB; Shnorhavorian M
    J Pediatr Urol; 2017 Dec; 13(6):632.e1-632.e7. PubMed ID: 28739373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nutritional aspects of idiopathic nephrolithiasis in Tunisian children.
    Alaya A; Sakly R; Nouri A; Najjar MF
    Arch Ital Urol Androl; 2011 Sep; 83(3):136-40. PubMed ID: 22187743
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective study of nephrolithiasis occurrence in children receiving cefotriaxone.
    Youssef DM; Sherief LM; Sherbiny HS; ElAttar MY; Sheikh AR; Fawzy FM; Adham T
    Nephrology (Carlton); 2016 May; 21(5):432-7. PubMed ID: 26369807
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium oxalate nephrolithiasis: urinary "medium size peptides"analysis using MALDI-TOF mass spectrometry.
    D'Addessi A; Bongiovanni L; Vittori M; Fanali C; Foschi N; Castagnola M; Bassi PF
    Arch Ital Urol Androl; 2010 Sep; 82(3):140-4. PubMed ID: 21121430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical, demographic, and laboratory characteristics of children with nephrolithiasis.
    Sas DJ; Becton LJ; Tutman J; Lindsay LA; Wahlquist AH
    Urolithiasis; 2016 Jun; 44(3):241-6. PubMed ID: 26467033
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current Trends, Evaluation, and Management of Pediatric Nephrolithiasis.
    Hernandez JD; Ellison JS; Lendvay TS
    JAMA Pediatr; 2015 Oct; 169(10):964-70. PubMed ID: 26302045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Urinary peptides and calcium oxalate nephrolithiasis, a combined approach: MALDI-TOF mass spectrometry and MicroBCA Protein Assay].
    Vittori M; D'Addessi A; Sacco E; Inzitari R; Fanali C; Totaro A; Bassi P
    Urologia; 2011; 78(3):227-32. PubMed ID: 21965035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fasting urinary calcium to creatinine ratio for the evaluation of calcium nephrolithiasis in adults.
    Sun L; Guo Z; Shan J; Jiang G
    Br J Biomed Sci; 2017 Apr; 74(2):101-103. PubMed ID: 28102104
    [No Abstract]   [Full Text] [Related]  

  • 59. Annual Incidence of Nephrolithiasis among Children and Adults in South Carolina from 1997 to 2012.
    Tasian GE; Ross ME; Song L; Sas DJ; Keren R; Denburg MR; Chu DI; Copelovitch L; Saigal CS; Furth SL
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):488-96. PubMed ID: 26769765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic difficulties with estimation of the cause of nephrolithiasis. Case presentation.
    Gadomska-Prokop K; Jobs K
    Arch Ital Urol Androl; 2011 Mar; 83(1):54-6. PubMed ID: 21585172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.